BrightSpring Health Services (BTSG)

• Market cap: $3.23B
• 1 day: 0.38%
• 5 days: 9.57%
• 1 month: 0.49%
• 3 months: 16.59%
• 6 months: 56.54%
• Year to date: 7.04%
• 1 year: 68.64%
• 5 years: 68.64%
• 10 years: 68.64%
• Sector: Healthcare
• Industry: Home Health Care Services

About: BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

Employees: 35,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

67,670% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $10K

486% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 7

67% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 5 (+2) [Q3]

54% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 28

32% more funds holding

Funds holding: 96 [Q2] → 127 (+31) [Q3]

26% more capital invested

Capital invested by funds: $2.24B [Q2] → $2.83B (+$592M) [Q3]

2.68% less ownership

Funds ownership: 115.0% [Q2] → 112.33% (-2.68%) [Q3]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $20 8% upside
• Avg. target: $22 18% upside
• High target: $27 46% upside

6 analyst ratings

• positive: 6 100%
• neutral: 0 0%
• negative: 0 0%

Morgan Stanley Erin Wright 39% 1-year accuracy 9 / 23 met price target	8% upside $20	Overweight Maintained	17 Dec 2024
CJS Securities Larry Solow 0% 1-year accuracy 0 / 1 met price target	46% upside $27	Market Outperform Initiated	12 Dec 2024
B of A Securities Joanna Gajuk 56% 1-year accuracy 5 / 9 met price target	13% upside $21	Buy Maintained	11 Dec 2024
Wells Fargo Stephen Baxter 24% 1-year accuracy 9 / 38 met price target	13% upside $21	Overweight Maintained	27 Nov 2024
UBS A.J. Rice 53% 1-year accuracy 9 / 17 met price target	19% upside $22	Buy Maintained	4 Nov 2024